Clinical Trial Update: Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis [Phase 2]

View source ↗

Summary

Phase II study evaluating toripalimab with stereotactic body radiotherapy in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stereotactic Body Radiotherapy
• Toripalimab (Toripalimab)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN